Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexios Matikas

Showing results (51-60 of 93) with videos related to

Pageof 10
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|March 12, 2025
Prognosis After Pathologic Complete Response to Neoadjuvant Therapy in Early-Stage Breast Cancer: A Population-Based StudyCaroline Boman, Christian Tranchell, Xingrong Liu, et al.
Critical Reviews in Oncology/Hematology|December 27, 2024
Grading the evidence for physical activity and any outcome in cancer survivors: An Umbrella review of 740 meta-analytic associationsPanagiotis Filis, Georgios Markozannes, Doris Sm Chan, et al.
BMC Cancer|April 24, 2014
Capecitabine in combination with oxaliplatin and bevacizumab (AXELOX) as 1st line treatment for fit and vulnerable elderly patients (aged >70 years) with metastatic colorectal cancer (mCRC): a multicenter phase II study of the Hellenic Oncology Research Group (HORG)Lambros Vamvakas, Alexios Matikas, Athanasios Karampeazis, et al.
ESMO Open|November 11, 2020
PD-1 protein and gene expression as prognostic factors in early breast cancerAlexios Matikas, Ioannis Zerdes, John Lövrot, et al.
Molecular Oncology|August 3, 2017
Expression of insulin-like growth factor-1 receptor in circulating tumor cells of patients with breast cancer is associated with patient outcomesMaria Spiliotaki, Dimitris Mavroudis, Maria Kokotsaki, et al.
Scientific Reports|August 6, 2024
Systematic review and feasibility study on pre-analytical factors and genomic analyses on archival formalin-fixed paraffin-embedded breast cancer tissueDimitrios Salgkamis, Emmanouil G Sifakis, Susanne Agartz, et al.
British Journal of Cancer|February 11, 2022
Detection of circulating tumour cells before and following adjuvant chemotherapy and long-term prognosis of early breast cancerAlexios Matikas, Athanasios Kotsakis, Stella Apostolaki, et al.
Anticancer Research|July 31, 2014
A case of herpes simplex-associated encephalitis after brain irradiation for lung cancer metastasesAlexios Matikas, Emmanouil Kontopodis, George Nintos, et al.
Molecular Oncology|March 3, 2020
Programmed death-ligand 1 gene expression is a prognostic marker in early breast cancer and provides additional prognostic value to 21-gene and 70-gene signatures in estrogen receptor-positive diseaseIoannis Zerdes, Emmanouil G Sifakis, Alexios Matikas, et al.
British Journal of Cancer|June 28, 2024
A population-based study on trajectories of HER2 status during neoadjuvant chemotherapy for early breast cancer and metastatic progressionCaroline Boman, Xingrong Liu, Louise Eriksson Bergman, et al.
Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
Journal of the National Comprehensive Cancer Network : JNCCN|March 12, 2025
Prognosis After Pathologic Complete Response to Neoadjuvant Therapy in Early-Stage Breast Cancer: A Population-Based StudyCaroline Boman, Christian Tranchell, Xingrong Liu, et al.
Critical Reviews in Oncology/Hematology|December 27, 2024
Grading the evidence for physical activity and any outcome in cancer survivors: An Umbrella review of 740 meta-analytic associationsPanagiotis Filis, Georgios Markozannes, Doris Sm Chan, et al.
BMC Cancer|April 24, 2014
Capecitabine in combination with oxaliplatin and bevacizumab (AXELOX) as 1st line treatment for fit and vulnerable elderly patients (aged >70 years) with metastatic colorectal cancer (mCRC): a multicenter phase II study of the Hellenic Oncology Research Group (HORG)Lambros Vamvakas, Alexios Matikas, Athanasios Karampeazis, et al.
ESMO Open|November 11, 2020
PD-1 protein and gene expression as prognostic factors in early breast cancerAlexios Matikas, Ioannis Zerdes, John Lövrot, et al.
Molecular Oncology|August 3, 2017
Expression of insulin-like growth factor-1 receptor in circulating tumor cells of patients with breast cancer is associated with patient outcomesMaria Spiliotaki, Dimitris Mavroudis, Maria Kokotsaki, et al.
Scientific Reports|August 6, 2024
Systematic review and feasibility study on pre-analytical factors and genomic analyses on archival formalin-fixed paraffin-embedded breast cancer tissueDimitrios Salgkamis, Emmanouil G Sifakis, Susanne Agartz, et al.
British Journal of Cancer|February 11, 2022
Detection of circulating tumour cells before and following adjuvant chemotherapy and long-term prognosis of early breast cancerAlexios Matikas, Athanasios Kotsakis, Stella Apostolaki, et al.
Anticancer Research|July 31, 2014
A case of herpes simplex-associated encephalitis after brain irradiation for lung cancer metastasesAlexios Matikas, Emmanouil Kontopodis, George Nintos, et al.
Molecular Oncology|March 3, 2020
Programmed death-ligand 1 gene expression is a prognostic marker in early breast cancer and provides additional prognostic value to 21-gene and 70-gene signatures in estrogen receptor-positive diseaseIoannis Zerdes, Emmanouil G Sifakis, Alexios Matikas, et al.
British Journal of Cancer|June 28, 2024
A population-based study on trajectories of HER2 status during neoadjuvant chemotherapy for early breast cancer and metastatic progressionCaroline Boman, Xingrong Liu, Louise Eriksson Bergman, et al.
Pageof 10